Europe's New Cyber Rules: Pure Global on MedTech's Security Hurdles

The European Union has rolled out tough new cybersecurity regulations for medical devices, forcing manufacturers to rethink their entire approach to product security. This episode dives into the practical challenges companies are facing, from securing legacy products to meeting intensive new documentation and surveillance demands. We explore the case of a German pacemaker manufacturer struggling to adapt its successful legacy devices to the new rules. Their story highlights the immense technical and financial pressures of implementing lifecycle-wide cybersecurity, a pain point many in the industry are now feeling. This week's key takeaways: 1. Is your legacy device portfolio a ticking time bomb under the new EU Cyber Resilience Act? 2. How do you integrate state-of-the-art cybersecurity into a medical device's design from day one? 3. What are the hidden operational costs of continuous post-market cybersecurity monitoring? 4. Does your Quality Management System truly treat cybersecurity as a patient safety issue? 5. How can you build a technical dossier that proves cybersecurity resilience to regulators? 6. Are your software development and update processes secure enough for the new standards? 7. What specific cybersecurity expertise does your regulatory team need to succeed? 8. How can you manage supply chain risks that introduce new cyber vulnerabilities? To learn more about navigating global MedTech regulations, contact us at [e-mail], visit https://pureglobal.com/, or explore our FREE AI tools and medical device database at https://pureglobal.ai/.